Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 3
1991 16
1992 15
1993 7
1994 2
1995 3
1996 8
1997 2
1998 2
1999 3
2000 3
2001 6
2002 1
2003 7
2004 4
2005 4
2006 6
2007 7
2008 7
2009 6
2010 7
2011 5
2012 5
2013 9
2014 8
2015 3
2016 8
2017 5
2018 4
2019 5
2020 3
2021 4
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
Noor NM, Lee JC, Bond S, Dowling F, Brezina B, Patel KV, Ahmad T, Banim PJ, Berrill JW, Cooney R, De La Revilla Negro J, de Silva S, Din S, Durai D, Gordon JN, Irving PM, Johnson M, Kent AJ, Kok KB, Moran GW, Mowat C, Patel P, Probert CS, Raine T, Saich R, Seward A, Sharpstone D, Smith MA, Subramanian S, Upponi SS, Wiles A, Williams HRT, van den Brink GR, Vermeire S, Jairath V, D'Haens GR, McKinney EF, Lyons PA, Lindsay JO, Kennedy NA, Smith KGC, Parkes M; PROFILE Study Group. Noor NM, et al. Among authors: probert cs. Lancet Gastroenterol Hepatol. 2024 May;9(5):415-427. doi: 10.1016/S2468-1253(24)00034-7. Epub 2024 Feb 22. Lancet Gastroenterol Hepatol. 2024. PMID: 38402895 Free PMC article. Clinical Trial.
Review article: cytomegalovirus and inflammatory bowel disease.
Sager K, Alam S, Bond A, Chinnappan L, Probert CS. Sager K, et al. Among authors: probert cs. Aliment Pharmacol Ther. 2015 Apr;41(8):725-33. doi: 10.1111/apt.13124. Epub 2015 Feb 16. Aliment Pharmacol Ther. 2015. PMID: 25684400 Free article. Review.
Oral submucosal fibrosis--a preventable disease.
Jayanthi V, Probert CS, Sher KS, Mayberry JF. Jayanthi V, et al. Among authors: probert cs. Gut. 1992 Jan;33(1):4-6. doi: 10.1136/gut.33.1.4. Gut. 1992. PMID: 1740275 Free PMC article. Review. No abstract available.
Mucins and inflammatory bowel disease.
Shirazi T, Longman RJ, Corfield AP, Probert CS. Shirazi T, et al. Among authors: probert cs. Postgrad Med J. 2000 Aug;76(898):473-8. doi: 10.1136/pmj.76.898.473. Postgrad Med J. 2000. PMID: 10908374 Free PMC article. Review.
Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury.
Carr DF, Ayehunie S, Davies A, Duckworth CA, French S, Hall N, Hussain S, Mellor HR, Norris A, Park BK, Penrose A, Pritchard DM, Probert CS, Ramaiah S, Sadler C, Schmitt M, Shaw A, Sidaway JE, Vries RG, Wagoner M, Pirmohamed M. Carr DF, et al. Among authors: probert cs. Pharmacol Ther. 2017 Apr;172:181-194. doi: 10.1016/j.pharmthera.2017.01.002. Epub 2017 Jan 27. Pharmacol Ther. 2017. PMID: 28132905 Review.
170 results